Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
Rika Hoshino(Nagasaki University), Michiaki Kohno(Yamaguchi University), Jiro Fujimoto(Harvard University), Takao Yamori(Institute of Applied Energy), Hiromi Wada(Kyoto University), Hiroya Oka(Kyoto University), Osamu Yoshida(Shikoku (Japan)), Takashi Tsuruo(Chemotherapy Foundation), Yutaka Shimada(Minamiaoyama Eye Clinic), Shigeki Arii(Kyoto University), Yuji Chatani(Gifu Pharmaceutical University)
Cited by 693
Related Papers
A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung
|New England Journal of Medicine|2004|839
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system
|International Immunology|2008|480